Which parameter is essential to monitor in neonates receiving amphotericin B?

Enhance your readiness for the MEDNAX Neonatal Nurse Practitioner Exam. Utilize flashcards, multiple-choice questions, and detailed explanations. Equip yourself for success!

Multiple Choice

Which parameter is essential to monitor in neonates receiving amphotericin B?

Explanation:
Amphotericin B carries a high risk of nephrotoxicity, especially in neonates, so monitoring renal function is essential. The drug can cause direct tubular injury and reduced kidney perfusion, leading to a fall in glomerular filtration with rising serum creatinine and BUN and decreased urine output. It also causes electrolyte losses (notably potassium and magnesium), so tracking electrolytes alongside renal markers helps detect toxicity early and guides dose adjustments or consideration of less nephrotoxic formulations. Liver enzymes, coagulation studies, and lipid levels aren’t the primary concerns with amphotericin B toxicity, so they’re not the key parameters to monitor for this therapy.

Amphotericin B carries a high risk of nephrotoxicity, especially in neonates, so monitoring renal function is essential. The drug can cause direct tubular injury and reduced kidney perfusion, leading to a fall in glomerular filtration with rising serum creatinine and BUN and decreased urine output. It also causes electrolyte losses (notably potassium and magnesium), so tracking electrolytes alongside renal markers helps detect toxicity early and guides dose adjustments or consideration of less nephrotoxic formulations. Liver enzymes, coagulation studies, and lipid levels aren’t the primary concerns with amphotericin B toxicity, so they’re not the key parameters to monitor for this therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy